Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Vivos Therapeutics, Inc. entered into Collaboration Agreement with South Palm Cardiovascular Associates, LLC valued at Formation of new management services organization AIM Florida, LLC; Vivos holds not less than 80% me (effective 2026-06-10).
- Action
- entry
- Agreement
- collaboration
- Counterparty
- South Palm Cardiovascular Associates, LLC
- Value
- Formation of new management services organization AIM Florida, LLC; Vivos holds not less than 80% me
- Effective
- 2026-06-10
Exact text from the filing
On June 10, 2026, Vivos Therapeutics, Inc. (the “Company”) entered into a Collaboration Agreement (the “Collaboration Agreement”) with South Palm Cardiovascular Associates, LLC, a Florida limited liability company (“SPCVA”), pursuant to which the parties agreed to collaborate in the formation and operation of a new management services organization to be known as AIM Florida, LLC (“AIM Florida”). AIM Florida is intended to provide administrative, operational, billing, payer-contracting, marketing, platform, data and other non-clinical support services to one or more affiliated professional clinical entities that will deliver sleep apnea diagnostic and treatment services to patients, with the collaboration initially focused on the Palm Beach County, Florida market. Under the Collaboration Agreement, the Company expects to hold not less than 80% of the membership interests in AIM Florida, and SPCVA expects to hold up to 20% of the membership interests, in each case subject to the negotiat
View on SEC.gov